World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
24591
World Ranking
1504
National Ranking
758

Andrew H. Kang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrew H. Kang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 249 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrew H. Kang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew H. Kang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrew H. Kang is affiliated with the University of Tennessee Health Science Center in the United States. Their research spans the fields of Medicine and Engineering, with significant contributions in subfields such as Electrical and Electronic Engineering, Immunology and Allergy, Molecular Biology, Pathology and Forensic Medicine, and Information Systems.

Their work covers a diverse array of scientific topics, prominently including Electronic Packaging and Soldering Technologies, 3D IC and TSV technologies, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Galectins and Cancer Biology, and Signaling Pathways in Disease.

Andrew H. Kang's recent publications illustrate a balance between biomedical and engineering sciences. Notable recent papers include:

  • Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway, 2020, Journal of Biological Chemistry
  • Role of Citrullinated Collagen in Autoimmune Arthritis, 2022, International Journal of Molecular Sciences
  • 1,25-Dihydroxyvitamin D3 and 20-Hydroxyvitamin D3 Upregulate LAIR-1 and Attenuate Collagen Induced Arthritis, 2021, International Journal of Molecular Sciences
  • Study of Parameter Tuning for the Curing Condition on ABF Type for Large FCBGA Package, 2022, 2022 IEEE 72nd Electronic Components and Technology Conference (ECTC)
  • Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer, 2025, Journal of sport and health science/Journal of Sport and Health Science

Frequent co-authors collaborating with Kang include:

  • David Brand
  • Linda K. Myers
  • Jeoung-Eun Park
  • Edward F. Rosloniec
  • Ae-Kyung Yi

Their work has been published predominantly in the following venues, demonstrating continued engagement with both biomedical and engineering audiences:

  • Journal of Biological Chemistry
  • International Journal of Molecular Sciences
  • IMAPSource Proceedings
  • 2022 IEEE 72nd Electronic Components and Technology Conference (ECTC)
  • Journal of sport and health science/Journal of Sport and Health Science

Best Publications

  • Autoimmunity to type II collagen an experimental model of arthritis.

    David E. Trentham;David E. Trentham;Alexander S. Townes;Alexander S. Townes;Andrew Kang

  • Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides.

    Arnold E. Postlethwaite;Jerome M. Seyer;Andrew H. Kang

  • Induction of arthritis with monoclonal antibodies to collagen.

    K Terato;K A Hasty;R A Reife;M A Cremer

  • The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor

    Arnold Postlethwaite;Ralph Snyderman;Ralph Snyderman;Andrew Kang

  • Collagen-induced arthritis, an animal model of autoimmunity

    Linda K. Myers;Edward F. Rosloniec;Edward F. Rosloniec;Michael A. Cremer;Michael A. Cremer;Andrew H. Kang;Andrew H. Kang

  • Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

    J M Stuart;M A Cremer;A S Townes;A H Kang

  • Collagen-and collagen peptide-induced chemotaxis of human blood monocytes.

    Arnold E. Postlethwaite;Andrew H. Kang

  • Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta.

    Postlethwaite Ae;Raghow R;Stricklin Gp;Poppleton H

  • Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats.

    David E. Trentham;Alexander S. Townes;Andrew H. Kang;John R. David

  • Immunopathogenesis of collagen arthritis.

    David D. Brand;Andrew H. Kang;Andrew H. Kang;Edward F. Rosloniec;Edward F. Rosloniec

  • Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.

    Margaret S. Hibbs;John R. Hoidal;Andrew H. Kang

  • Type II collagen autoimmunity in otosclerosis and Meniere's Disease

    T. J. Yoo;J. M. Stuart;A. H. Kang;A. S. Townes

  • The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease

    M. A. Cremer;Edward F. Rosloniec;Andrew H. Kang

  • An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen

    Edward F. Rosloniec;David D. Brand;Linda K. Myers;Karen B. Whittington

  • The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis.

    Karen A. Hasty;Robert A. Reife;Andrew H. Kang;John M. Stuart

  • Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice.

    John M. Stuart;Alexander S. Townes;Andrew H. Kang

  • Collagen Autoimmune Arthritis

    John M. Stuart;Alexander S. Townes;Andrew H. Kang

  • Collagen-induced arthritis in rats

    John M. Stuart;Michael A. Cremer;Saryu N. Dixit;Andrew H. Kang

  • Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay.

    John M. Stuart;Eugene H. Huffstutter;Alexander S. Townes;Andrew H. Kang

  • Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis

    Philippe Van den Steen;Paul Proost;Bernard Grillet;David D Brand

Frequent Co-Authors

John M. Stuart
John M. Stuart University of Tennessee Health Science Center
Arnold E. Postlethwaite
Arnold E. Postlethwaite University of Tennessee Health Science Center
Jerome M. Seyer
Jerome M. Seyer University of Tennessee Health Science Center
David D. Brand
David D. Brand University of Tennessee Health Science Center
Karen A. Hasty
Karen A. Hasty University of Tennessee Health Science Center
Rajendra Raghow
Rajendra Raghow University of Tennessee Health Science Center
Jerome Gross
Jerome Gross Harvard University
Edwin H. Beachey
Edwin H. Beachey University of Tennessee Health Science Center
Ralph Snyderman
Ralph Snyderman Duke University
Jorma Keski-Oja
Jorma Keski-Oja University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing a related career in healthcare often begins with foundational nursing degrees. Many students transition into the field through programs like the accelerated FNP, which fast-tracks nurse practitioner qualifications. These programs are designed to build specialized knowledge rapidly, paving the way for advanced clinical roles.

Non-nurses looking to enter the field can opt for online ABSN programs for non nurses. These degree options provide a streamlined pathway from a different background, helping students gain essential nursing skills with flexible schedules.

When choosing a program, accessibility is key. Exploring options like the easiest ABSN programs to get into can offer a quicker entry route without compromising education quality. Similarly, those aiming to begin their careers swiftly may look into LPN schools easy to get into, which provide practical training with lower barriers to admission.

Each of these pathways supports a strong foundation in healthcare, essential for careers related to Immunology. Understanding these options helps prospective students plan their educational journey to meet both personal and professional goals effectively.

Best Scientists Citing Andrew H. Kang

Trending Scientists

Recently Published Articles